Acumen Pharmaceuticals, Inc. Share Price
Equities
ABOS
US00509G2093
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.25 USD | +0.93% | +2.20% | -15.36% |
04/04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
04/04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 195M 16.29B |
---|---|---|---|---|---|
Net income 2024 * | -68M -5.67B | Net income 2025 * | -93M -7.76B | EV / Sales 2024 * | - |
Net cash position 2024 * | 121M 10.08B | Net cash position 2025 * | 258M 21.49B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.66
x | P/E ratio 2025 * |
-2.06
x | Employees | 52 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.87% |
Latest transcript on Acumen Pharmaceuticals, Inc.
1 day | +0.93% | ||
1 week | +2.20% | ||
Current month | +0.93% | ||
1 month | -18.95% | ||
3 months | +4.50% | ||
6 months | +71.05% | ||
Current year | -15.36% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/06/01 |
Jim Doherty
PSD | President | 56 | 01/02 |
Matthew Zuga
DFI | Director of Finance/CFO | 58 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/06/01 |
Director/Board Member | 55 | 01/22/01 | |
Jeffrey Ives
BRD | Director/Board Member | 73 | 01/14/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 3.25 | +0.93% | 195,492 |
30/24/30 | 3.22 | +1.26% | 82,937 |
29/24/29 | 3.18 | +0.32% | 305,274 |
26/24/26 | 3.17 | -0.63% | 140,701 |
25/24/25 | 3.19 | +0.31% | 167,647 |
Delayed Quote Nasdaq, May 02, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.36% | 195M | |
+0.67% | 42.4B | |
+44.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- ABOS Stock